2026 International Congress Archives - Page 101 of 208

Identification of Parkinson’s Disease Tremor-Related Functional Network Topographies Using 3.0 T rs-fMRI

ZY. Lin, J. Li, ZT. Zeng, DY. Li (Shanghai, China)
Identification of Phenotypes in a Prospective Parkinson’s Disease Cohort Using Digital Wearable Monitoring

A. Saenz, I. Gabilondo, S. Seijo, A. Ochoa, U. Zalabarria, I. Cuenca, B. Tijero, T. Fernández, M. Ruiz, M. Acera, J. Gomez, R. Del Pino (Barakaldo, Spain)
Identifying Informative Speech Tasks for Detecting Clinically Relevant Changes in Parkinson’s Disease

T. Thies, I. Rubi-Fessen, J. Strelow, J. Tröger, D. Mücke, M. Barbe (Cologne, Germany)
Identifying Parkinson’s Disease Subtypes Using Fluid Biomarkers Clustering in the PPMI Cohort

C. Mcintyre, N. Maki, J. Li, J. Ruiz Tejeda, R. Rajmohan, N. Phielipp (Chicago, USA)
Identifying Peripheral Stimulation Sites to Treat Parkinson’s Disease Gait Impairments

N. Hennessy, M. Bravo, J. Fallon, M. Shoushtarian (East Melbourne, Australia)
Image-Guided DBS Programming in Dystonia: Experience from a Tertiary Public Brazilian Center

M. Soares, J. Nogueira, J. Gomes, M. Bezerra (Recife, Brazil)
Immigration status and Parkinson’s disease: a retrospective matched cohort study

A. Peral Quirós, N. Caballol Pons, P. Lombardo, A. Planas Ballvé, MI. Gómez-Ruiz, A. ávila Rivera (Sant Joan Despí, Spain)
Immune-mediated Chorea in Antiphospholipid Syndrome: Normalization of FDG-PET and Neurofilament as Markers of Treatment Response.

L. Peraferrer-Montesinos, J. Martínez-Rodríguez, A. Fernández-Lebrero, M. Viles-Garcia, E. Carrillo Villamizar, P. Plaza-López, V. Puente-Periz, I. Navalpotro-Gómez (Barcelona, Spain)
Immunological characteristics of Parkinson’s disease by clinical form and stage

S. Jumanazarova, E. Abduqodirov, R. Matmurodov, S. Mamatova (Tashkent, Uzbekistan)
Immunological principles of levodopa therapy in Parkinson’s disease

N. Naimov, B. Muminov, S. Jumanazarova, R. Matmurodov, H. Daminova (Tashkent, Uzbekistan)